l carnitine tmao koeth 2013 nature medicine γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to γ-Butyrobetaine Is a Proatherogenic Intermediate

Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect Meat metabolizing bacteria in atherosclerosis Nature Medicine Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications Unraveling the Formation Mechanisms of Trimethylamine N Oxide and Its Inhibition by Food Ingredients: Toward Cardioprotective Food Development Journal of Agricultural and Food Chemistry

SKU: 94268084571 · From lagence-mr.com